485 related articles for article (PubMed ID: 10066389)
1. Glutaryl-CoA dehydrogenase deficiency presenting as 3-hydroxyglutaric aciduria.
Nyhan WL; Zschocke J; Hoffmann G; Stein DE; Bao L; Goodman S
Mol Genet Metab; 1999 Mar; 66(3):199-204. PubMed ID: 10066389
[TBL] [Abstract][Full Text] [Related]
2. Novel mutations of the glutaryl-CoA dehydrogenase gene in two Japanese patients with glutaric aciduria type I.
Ikeda H; Kimura T; Ikegami T; Kato M; Matsunaga A; Yokoyama S; Yamaguchi S; Ohura T; Hayasaka K
Am J Med Genet; 1998 Dec; 80(4):327-9. PubMed ID: 9856558
[TBL] [Abstract][Full Text] [Related]
3. [Macrocephaly and dystonic cerebral palsy in a child with type I glutaric aciduria].
Plöchl E; Christensen E; Colombo JP; Weiss-Wichert P; Wenger E
Padiatr Padol; 1991; 26(2):97-101. PubMed ID: 1945471
[TBL] [Abstract][Full Text] [Related]
4. [Glutaric aciduria type I: an organic acidemia without acidosis with severe movement disorders].
Prats Viñas J
Neurologia; 2001 Oct; 16(8):337-41. PubMed ID: 11738010
[No Abstract] [Full Text] [Related]
5. [Macrocephaly as the initial manifestation of glutaryl-CoA-dehydrogenase deficiency (glutaric aciduria type I)].
Trefz FK; Hoffmann GF; Mayatepek E; Lichter-Konecki U; Weisser J; Otten A; Wendel U; Rating D; Bremer HJ
Monatsschr Kinderheilkd; 1991 Nov; 139(11):754-8. PubMed ID: 1775140
[TBL] [Abstract][Full Text] [Related]
6. [Glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I)].
Hayasaka K; Ikeda H
Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):332-5. PubMed ID: 9590060
[No Abstract] [Full Text] [Related]
7. Glutaryl-CoA dehydrogenase mutations in glutaric acidemia (type I): review and report of thirty novel mutations.
Goodman SI; Stein DE; Schlesinger S; Christensen E; Schwartz M; Greenberg CR; Elpeleg ON
Hum Mutat; 1998; 12(3):141-4. PubMed ID: 9711871
[TBL] [Abstract][Full Text] [Related]
8. Dystonia and dyskinesia in glutaric aciduria type I: clinical heterogeneity and therapeutic considerations.
Kyllerman M; Skjeldal OH; Lundberg M; Holme I; Jellum E; von Döbeln U; Fossen A; Carlsson G
Mov Disord; 1994 Jan; 9(1):22-30. PubMed ID: 8139602
[TBL] [Abstract][Full Text] [Related]
9. Glutaric aciduria type I: a common cause of episodic encephalopathy and spastic paralysis in the Amish of Lancaster County, Pennsylvania.
Morton DH; Bennett MJ; Seargeant LE; Nichter CA; Kelley RI
Am J Med Genet; 1991 Oct; 41(1):89-95. PubMed ID: 1951469
[TBL] [Abstract][Full Text] [Related]
10. D-2-hydroxyglutaric aciduria and glutaric aciduria type 1 in siblings: coincidence, or linked disorders?
Korman SH; Salomons GS; Gutman A; Brooks R; Jakobs C
Neuropediatrics; 2004 Jun; 35(3):151-6. PubMed ID: 15248096
[TBL] [Abstract][Full Text] [Related]
11. Pathomechanisms of neurodegeneration in glutaryl-CoA dehydrogenase deficiency.
Kölker S; Koeller DM; Okun JG; Hoffmann GF
Ann Neurol; 2004 Jan; 55(1):7-12. PubMed ID: 14705106
[TBL] [Abstract][Full Text] [Related]
12. Glutaric aciduria type II: evidence for a defect related to the electron transfer flavoprotein or its dehydrogenase.
Christensen E; Kølvraa S; Gregersen N
Pediatr Res; 1984 Jul; 18(7):663-7. PubMed ID: 6433313
[TBL] [Abstract][Full Text] [Related]
13. [Development of brain atrophy, therapy and therapy monitoring in glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency)].
Lawrenz-Wolf B; Herberg KP; Hoffmann GF; Hunneman DH; Lehnert W; Hanefeld F
Klin Padiatr; 1993; 205(1):23-9. PubMed ID: 8445849
[TBL] [Abstract][Full Text] [Related]
14. Glutaryl-CoA dehydrogenase deficiency in Spain: evidence of two groups of patients, genetically, and biochemically distinct.
Busquets C; Merinero B; Christensen E; Gelpí JL; Campistol J; Pineda M; Fernández-Alvarez E; Prats JM; Sans A; Arteaga R; Martí M; Campos J; Martínez-Pardo M; Martínez-Bermejo A; Ruiz-Falcó ML; Vaquerizo J; Orozco M; Ugarte M; Coll MJ; Ribes A
Pediatr Res; 2000 Sep; 48(3):315-22. PubMed ID: 10960496
[TBL] [Abstract][Full Text] [Related]
15. Variable clinical and biochemical presentation of seven Spanish cases with glutaryl-CoA-dehydrogenase deficiency.
Merinero B; Pérez-Cerdá C; Font LM; Garcia MJ; Aparicio M; Lorenzo G; Martinez Pardo M; Garzo C; Martinez-Bermejo A; Pascual Castroviejo I
Neuropediatrics; 1995 Oct; 26(5):238-42. PubMed ID: 8552212
[TBL] [Abstract][Full Text] [Related]
16. Glutaric aciduria type I with high residual glutaryl-CoA dehydrogenase activity.
Pineda M; Ribes A; Busquets C; Vilaseca MA; Aracil A; Christensen E
Dev Med Child Neurol; 1998 Dec; 40(12):840-2. PubMed ID: 9881681
[TBL] [Abstract][Full Text] [Related]
17. Glutaryl-CoA dehydrogenase deficiency: region-specific analysis of organic acids and acylcarnitines in post mortem brain predicts vulnerability of the putamen.
Kölker S; Hoffmann GF; Schor DS; Feyh P; Wagner L; Jeffrey I; Pourfarzam M; Okun JG; Zschocke J; Baric I; Bain MD; Jakobs C; Chalmers RA
Neuropediatrics; 2003 Jun; 34(5):253-60. PubMed ID: 14598231
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity and specificity of free and total glutaric acid and 3-hydroxyglutaric acid measurements by stable-isotope dilution assays for the diagnosis of glutaric aciduria type I.
Baric I; Wagner L; Feyh P; Liesert M; Buckel W; Hoffmann GF
J Inherit Metab Dis; 1999 Dec; 22(8):867-81. PubMed ID: 10604139
[TBL] [Abstract][Full Text] [Related]
19. Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency.
Hoffmann GF; Athanassopoulos S; Burlina AB; Duran M; de Klerk JB; Lehnert W; Leonard JV; Monavari AA; Müller E; Muntau AC; Naughten ER; Plecko-Starting B; Superti-Furga A; Zschocke J; Christensen E
Neuropediatrics; 1996 Jun; 27(3):115-23. PubMed ID: 8837070
[TBL] [Abstract][Full Text] [Related]
20. Significance of bound glutarate in the diagnosis of glutaric aciduria type I.
Ribes A; Riudor E; Briones P; Christensen E; Campistol J; Millington DS
J Inherit Metab Dis; 1992; 15(3):367-70. PubMed ID: 1405471
[No Abstract] [Full Text] [Related]
[Next] [New Search]